Skip to main content
Log in

Complete Response of Esophageal Cancer Achieved by Combination Therapy with 5-Fluorouracil, Low-Dose Cisplatin, and Radiation: Report of a Case

  • Published:
Surgery Today Aims and scope Submit manuscript

2

per day, from days 1–5 combined with the daily administration of low-dose cisplatin, 10 mg/m2 per day before each fraction of radiation, given as 2 Gy each time, throughout the entire treatment period of 3 weeks beginning on day 1. The benefits of our preoperative chemoradiation therapy included no severe side effects, down-staging and resectability of the tumor, as well as a pathological complete response, which could prolong the survival time. Our experience of this case prompts us to recommend the concurrent daily preoperative chemoradiation therapy for patients with locally advanced esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

(Received for publication on June 20, 1997; accepted on Jan. 6, 1998)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimoyama, S., Konishi, T., Kawahara, M. et al. Complete Response of Esophageal Cancer Achieved by Combination Therapy with 5-Fluorouracil, Low-Dose Cisplatin, and Radiation: Report of a Case. Surg Today 28, 1163–1167 (1998). https://doi.org/10.1007/s005950050305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005950050305

Navigation